GXI Highlights

News and Updates

The optimized DPP-IV Inhibitor, Zemiglo

Zemiglo is the optimized DPP-IV Inhibitor, because of its five unique characteristics like Potent Efficacy, Stable Glycemic Control, Beyond Glycemic Control, Reliable Safety and Better Compliance.

New GXI Corporate Center

On April 30, 2019, GXI inaugurated its own Corporate Center located in Buencamino St., Cupang, Muntinlupa city.

SAATIN ang ATORVASTATIN na sariling atin

GXI's ATORVASTATIN (SAATIN) was introduced to the medical community with the Filipiniana inspired marketing.

Recent Product Updates

Newest product listings

TAZUR 4 g/500 mg

TAZUR 4g/500 mg I.V is used for the treatment of serious bacterial infections caused by susceptible strains of beta-lactamase producing organisims...

View Details

MPEN 1000

MPEN 1000 is used in the treatment of susceptible infections, including intra-abdominal infections, meningitis, respiratory tract infections...

View Details

Panwin: One of a Kind Proton Pump Inhibitor

Panwin 40mg IV for injection is a third generation Proton pump inhibitor that reduces the production of gastric acid by blocking the enzyme in the wall of the stomach that produces acid.

View article


Seraseal® is a new and innovative hemostatic agent that is designed to stop bleeding on contact, and within seconds for arterial hemorrhages.

View article

In affiliation with: